2,250
Views
19
CrossRef citations to date
0
Altmetric
CLINICAL STUDY

Effects of Manidipine and Nifedipine on Blood Pressure and Renal Function in Patients with Chronic Renal Failure: A Multicenter Randomized Controlled Trial

, , & , M.D.
Pages 681-689 | Published online: 07 Jul 2009

References

  • Whelton P.K. Epidemiology of hypertension. Lancet 1994; 344: 101–106
  • Working Group on Primary Prevention of Hypertension. Report of the National High Blood Pressure Education Program Working Group on Primary Prevention of Hypertension. Archives of Internal Medicine 1993; 151: 186–208
  • The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Archives of Internal Medicine 1993; 153: 154–183
  • Danielson H., Kornerup H., Olsen S., Posberg V. Arterial hypertension in chronic glomerulonephritis. An analysis of 310 cases. Clinical Nephrology 1983; 19: 3353–3358
  • Brazy P.C., Fitzwilliam J.F. Progressive renal disease: role of race and antihypertensive medications. Kidney International 1990; 37: 1113–1119
  • The National High Blood Pressure Education Program Working Group: National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes. Hypertension 1994; 8: 2–6
  • Epstein M. Calcium antagonists and renal protection: current status and future perspectives. Archives of Internal Medicine 1992; 152: 1573–1584
  • Bretzel R.G. Protecting the residual renal function: which drugs of choice?. American Journal of Hypertension 1997; 10: 159s–166s
  • Takabatake T., Ohta H., Sasaki T., Satoh S., Ohta K., Ise T., Kobayashi K. Renal effects of manidipine hydrochloride. European Journal of Clinical Pharmacology 1993; 45: 321–325
  • Gault M.H., Longerich L.L., Harnett J.D., Wesolowsky C. Predicting glomerular function from adjusted serum creatinine. Nephron 1992; 62: 249–256
  • Neaton J.D., Grimm R.H., Jr., Prineas R.J. Treatment of mild hypertension study. JAMA 1993; 270: 713–724
  • Elliot W.J. Drug therapy and drops out in a tertiary hypertension clinic. American Journal of Hypertension 1994; 25: 1356
  • Fogari R., Zoppi A., Corradi L., Preti P., Malalamani G.D., Mugellini A. Effect of different dyhydropyridine calcium antagonist on plasma norepinephrine in essential hypertension. J. Hypertens. 2000; 18: 1871–1875
  • Van Zwieten P.A., Pfaffendorf M., Mancia G. Attempts to improve the selectivity of calcium antagonistic drugs. Blood Pressure 1996; 5(suppl 5)7–9
  • Epstain M. Calcium antagonist and the kidney. American Journal of Hypertension 1993; 6: 251s–259s
  • Sabbatini M., Leonardi A., Testa R., Vitaioli L., Amenta F. Effects of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats. Hypertension 2000; 35: 775–779
  • Keane W.J., Raij L. Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules. Laboratory Investigation 1985; 52: 599–604

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.